Enhanced Genomics ('Enhanced'), the biotechnology company pioneering 3D multi-omics to rapidly identify high-confidence, ...

After leading AI-genomics initiatives at Illumina and conducting cancer research in Arizona, Bageerathan returned to India in 2025 with a bold mission: to build the missing infrastructure for ...

The Global Bioinformatics Market is expected to grow at a rate of 13-14% by 2029. The rising government initiatives and ...

Rett syndrome is a devastating rare genetic childhood disorder primarily affecting girls. Merely 1 out of 10,000 girls are ...

OutSee, a genomics and drug discovery company pioneering a unique AI-based predictive genomics approach to target discovery, ...

Cambridge genomics and drug discovery startup OutSee has secured £1.8 million seed funding led by Ahren Innovation Capital ...

"The discovery was made in a West African parasite population during a study led by Dr. Abhinaya Venkatesan, a researcher at ...

"Our partnership with The ALBORADA Drug Discovery Institute showcases the transformative power of 3D multi-omics in drug discovery," said Dr. Dan Turner, CSO of Enhanced Genomics.

Dr. John Skidmore, CSO at The ALBORADA Drug Discovery Institute, added: "Using the insights provided by Enhanced's technology, we have gained new actionable targets operating by a range of mechanisms.

Dr. John Skidmore, CSO at The ALBORADA Drug Discovery Institute, added: "Using the insights provided by Enhanced's technology, we have gained new actionable targets operating by a range of mechanisms.